Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mitchison

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
American Journal of Respiratory and Critical Care Medicine|April 5, 2005
The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosisFrik A Sirgel, P Bernard Fourie, Peter R Donald, et al.
Tuberculosis (Edinburgh, Scotland)|December 8, 2014
HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic targetYanmin Hu, Alexander Liu, Maria C Menendez, et al.
Lancet (London, England)|October 1, 1988
Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in TranskeiJ I Strang, H H Kakaza, D G Gibson, et al.
Arthritis and Rheumatism|January 1, 1996
Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trialJ Sieper, S Kary, H Sörensen, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosisP R Donald, F A Sirgel, F J Botha, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2000
A multicentre study of the early bactericidal activity of anti-tuberculosis drugsF A Sirgel, P R Donald, J Odhiambo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 31, 2008
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosisR Rustomjee, C Lienhardt, T Kanyok, et al.
Journal of Clinical Microbiology|May 11, 2012
Optimizing outpatient serial sputum colony counting for studies of tuberculosis treatment in resource-poor settingsDerek J Sloan, Elizabeth L Corbett, Anthony E Butterworth, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Early bactericidal activity of paromomycin (aminosidine) in patients with smear-positive pulmonary tuberculosisP R Donald, F A Sirgel, T P Kanyok, et al.
The New England Journal of Medicine|October 23, 2014
High-dose rifapentine with moxifloxacin for pulmonary tuberculosisAmina Jindani, Thomas S Harrison, Andrew J Nunn, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
American Journal of Respiratory and Critical Care Medicine|April 5, 2005
The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosisFrik A Sirgel, P Bernard Fourie, Peter R Donald, et al.
Tuberculosis (Edinburgh, Scotland)|December 8, 2014
HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic targetYanmin Hu, Alexander Liu, Maria C Menendez, et al.
Lancet (London, England)|October 1, 1988
Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in TranskeiJ I Strang, H H Kakaza, D G Gibson, et al.
Arthritis and Rheumatism|January 1, 1996
Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trialJ Sieper, S Kary, H Sörensen, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosisP R Donald, F A Sirgel, F J Botha, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2000
A multicentre study of the early bactericidal activity of anti-tuberculosis drugsF A Sirgel, P R Donald, J Odhiambo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 31, 2008
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosisR Rustomjee, C Lienhardt, T Kanyok, et al.
Journal of Clinical Microbiology|May 11, 2012
Optimizing outpatient serial sputum colony counting for studies of tuberculosis treatment in resource-poor settingsDerek J Sloan, Elizabeth L Corbett, Anthony E Butterworth, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Early bactericidal activity of paromomycin (aminosidine) in patients with smear-positive pulmonary tuberculosisP R Donald, F A Sirgel, T P Kanyok, et al.
The New England Journal of Medicine|October 23, 2014
High-dose rifapentine with moxifloxacin for pulmonary tuberculosisAmina Jindani, Thomas S Harrison, Andrew J Nunn, et al.
Pageof 19